Market Research Report
Global Anti-malarial Medicines Market 2018-2022
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||711705|
|Published||Content info||117 Pages
Delivery time: 1-2 business days
|Global Anti-malarial Medicines Market 2018-2022|
|Published: September 21, 2018||Content info: 117 Pages||
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Technavio's analysts forecast the Global Anti-malarial Medicines Market to grow at a CAGR of 4.76% during the period 2018-2022.
The report covers the present scenario and the growth prospects of the anti-malarial medicines market. To calculate the market size, the report considers the revenue generated by sales of anti-malarial drugs across the globe.
The market is divided into the following segments based on geography:
Technavio's report, Anti-malarial Medicines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.